- Hepatocyte SphK2 maintains the homeostasis of lipid metabolism in NAFLDRen, Xiaoling; Ding, Xin; Chen, Wei; Li, Rui; Lan, TianInternational Digestive Disease Forum (IDDF), Hong Kong, PEOPLES R CHINA, 2023-06-10 To 2023-06-11.
- NOVEL, FIRST-IN-CLASS, FATTY ACID SYNTHASE (FASN) INHIBITOR TVB-2640 DEMONSTRATES ROBUST CLINICAL EFFICACY AND SAFETY IN A GLOBAL PHASE 2 RANDOMIZED PLACEBO-CONTROLLED NASH TRIAL (FASCINATE-1) CONDUCTED IN THE US AND CHINALoomba, Rohit; Rinella, Mary E.; Harrison, Stephen A.; Wong, Vincent; Ratziu, Vlad; Gores, Gregory J.; Neuschwander-Tetri, Brent A.; Mohseni, Rizwana; Lucas, Kathryn Jean; Gutierrez, Julio A.; Perry, Robert; Rahimi, Robert S.; Trotter, James F.; Deng, Hong; Xie, Qing; Zhang, Jing; Wu, Lixian; You, Hong; Zhong, Bihui; Hou, JinLin; Yang, Yongfeng; Lu, Yan; He, Handan; Palmer, Melissa; Wu, Jinzi; Grimmer, Katharine; McCulloch, William; O'Farrell, Marie; Martins, Eduardo B.; Kemble, George72nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, ELECTR NETWORK, 2021-11-12 To 2021-11-15.
- NLRP6 ALLEVIATE NAFLD PROGRESSION VIA RESCUING IMPAIRED AUTOPHAGY CAUSED BY LIPOTOXICITY IN HUMAN OVER-EXPRESSING MICEZhang, Yijie; Li, Xu, Sr.; Li, Yang; Chen, Tingting; Zhang, Yan
期刊论文
Enhanced A-FABP expression in visceral fat: potential contributor to the progression of NASH
13阅读
